Ionic liquid formulations that stabilise a range of payloads, antibodies and RNA-based systems, allowing pharmaceuticals to be storied in solution at room temperature.
A simple, scalable and cost-effective polymerisation method for synthesis of a class of novel, multifunctional, sequence-controlled, degradable and biocompatible polymers.
Biodegradable, second-harmonic generating nanoprobes for targeted, high-resolution in vivo tumour imaging
A next generation surgical robotics platform for ultra-minimally invasive surgery via a single port, offering bimanual haptic control and enabling autonomous surgical tasks.
Inducible systems developed for use in Mycoplasma species. These tools will contribute to the exploitation of Mycoplasma as a synthetic biology asset.
Novel compounds with dual DNA-PK/AKT inhibitor activity for the treatment of platinum-resistant cancers.
Use of short/medium chain fatty acids, including valerate and bile salt hydrolase (BSH) for the treatment and prevention of recurrent C. difficile infection
A set of microRNAs for predicting small-for-gestational-age (SGA) births based on the measurement of maternal blood samples taken in early pregnancy (gestation week 12 onwards).
Portable and designed to minimise discomfort, this device measures the contact and shear characteristics of skin, with applications in a wide range of skin-object interactions.
An improved SARS-CoV-2 spike protein subunit (S1) antigen and two exceptional ELISA assay formats for highly specific and sensitive serological detection and measurement of antibodies to SARS-CoV-2